This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Deppermann, K M Articles by Koeppe, P Search for Related Content PubMed PubMed Citation Articles by Deppermann, K M Articles by Koeppe, P

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1989 November; 33(11): 1901-1907

Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid.

K M Deppermann, H Lode, G Höffken, G Tschink, C Kalz and P Koeppe

Medical Department, Klinikum Steglitz, Freie Universität Berlin, Federal Republic of Germany.

ABSTRACT

Two randomized double-blind crossover studies and one randomized crossover study were performed to document possible drug-drug interactions between antacids (aluminum magnesium hydroxide, 10 ml per dose for 10 doses), antimuscarinic drugs (pirenzepine, 50 mg per dose for 4 doses), and H2-blockers (ranitidine, 150 mg per dose for 3 doses) and amoxicillin (1,000 mg), cephalexin (1,000 mg), doxycycline (200 mg), and amoxicillin-clavulanic acid (625 mg). Ten healthy volunteers participated in each study. Concentrations in serum and urine were measured by bioassay, and pharmacokinetic parameters were calculated by the usual open one- or two-compartment models (statistics were determined by the Wilcoxon test). The antacid, pirenzepine, and ranitidine had no influence on the bioavailability of amoxicillin, cephalexin, and amoxicillin-clavulanic acid. Only small differences could be observed in the pharmacokinetic parameters, but they are not of therapeutic importance. However, the antacid caused a significant (P less than 0.01) reduction in the gastrointestinal absorption of doxycycline (area under the concentration-time curve, 38.6 +/- 22.7 mg.h/liter, fasting; 6.0 +/- 3.2 mg.h/liter, with antacid), resulting in subtherapeutic levels of doxycycline.

---

Antimicrob Agents Chemother. 1989 November; 33(11): 1901-1907

This article has been cited by other articles:

• Zinner, S. H., Gilbert, D., Lubenko, I. Yu., Greer, K., Firsov, A. A. (2008). Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline. J Antimicrob Chemother 61: 629-635 [Abstract] [Full Text]  
• Grunder, G., Zysset-Aschmann, Y., Vollenweider, F., Maier, T., Krahenbuhl, S., Drewe, J. (2006). Lack of Pharmacokinetic Interaction between Linezolid and Antacid in Healthy Volunteers. Antimicrob. Agents Chemother. 50: 68-72 [Abstract] [Full Text]  
• Madaras-Kelly, K., Michas, P., George, M., May, M. P., Adejare, A. (2004). A Randomized Crossover Study Investigating the Influence of Ranitidine or Omeprazole on the Pharmacokinetics of Cephalexin Monohydrate. J Clin Pharmacol 44: 1391-1397 [Abstract] [Full Text]